06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.03
+1.49%Margins
Gross margin
23.1%
EBITDA margin
-2092.5%
EBIT margin
-2699.4%
Net margin
-2740.1%
FCF margin
-1923.0%
-33.0%
Return on equity
-22.0%
Return on assets
-27.0%
Return on invested capital
0.01x
Asset turnover
-HKD 158.1M
Cash from operations
HKD 0.04
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025